ERIS
Invest with MTF
Invest Now
Invest in Eris Lifesciences with 3.34X leverage
Performance
- Low
- ₹1,404
- High
- ₹1,442
- 52 Week Low
- ₹1,097
- 52 Week High
- ₹1,910
- Open Price₹1,434
- Previous Close₹1,427
- Volume41,993
- 50 DMA₹1,486.35
- 100 DMA₹1,536.68
- 200 DMA₹1,534.85
Investment Returns
- Over 1 Month -7.84%
- Over 3 Month -11.73%
- Over 6 Month -21.62%
- Over 1 Year + 14.72%
Smart Investing Starts Here Start SIP with Eris Lifesciences for Steady Growth!
Eris Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 47.1
- PEG Ratio
- 2.4
- Market Cap Cr
- 19,576
- P/B Ratio
- 6.3
- Average True Range
- 47.34
- EPS
- 30.02
- Dividend Yield
- 0.5
- MACD Signal
- -40.23
- RSI
- 44.6
- MFI
- 29.26
Eris Lifesciences Financials
Eris Lifesciences Technicals
EMA & SMA
Current Price
₹1,413.20
-14
(-0.98%)
- Bearish Moving Average 11
- Bullish Moving Average 5
- 20 Day
- ₹1,425.43
- 50 Day
- ₹1,486.35
- 100 Day
- ₹1,536.68
- 200 Day
- ₹1,534.85
Resistance and Support
1419.6
- R3 1,472.50
- R2 1,457.00
- R1 1,435.10
- S1 1,397.70
- S2 1,382.20
- S3 1,360.30
Eris Lifesciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-24 | Preferential issue of shares | Inter-alia, To consider the protposal of issuance ofequity shares of the Company by way of a preferential issue for consideration other than cash.. per share(601%)Interim Dividend |
| 2025-11-12 | Quarterly Results | |
| 2025-08-05 | Quarterly Results | |
| 2025-05-19 | Audited Results | |
| 2025-02-07 | Interim Dividend |
Eris Lifesciences F&O
About Eris Lifesciences
- NSE Symbol
- ERIS
- BSE Symbol
- 540596
- Chairperson & Managing Director
- Mr. Amit Bakshi
- ISIN
- INE406M01024
Similar Stocks to Eris Lifesciences
Eris Lifesciences FAQs
Eris Lifesciences share price is ₹1,413 As on 06 February, 2026 | 01:22
The Market Cap of Eris Lifesciences is ₹19576.1 Cr As on 06 February, 2026 | 01:22
The P/E ratio of Eris Lifesciences is 47.1 As on 06 February, 2026 | 01:22
The PB ratio of Eris Lifesciences is 6.3 As on 06 February, 2026 | 01:22
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.